CLINICAL_TRIALS
trial_result
· 2016-12-14
Clinical Trial Update: Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery Lesions [NA]
Summary
Pharmacokinetics study results for everolimus in Absorb bioresorbable vascular scaffold in patients with coronary artery disease and stenosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abbott Medical Devices | Conditions: Coronary Artery Disease, Coronary Artery Stenosis | NA | Status: COMPLETED | Results posted: 2016-12-14